Clinical Trial Update: Cenobamate Efficacy in Individuals With Autoimmune Epilepsy

View source ↗

Summary

A clinical trial update indicates cenobamate is being studied for autoimmune epilepsy, with enrollment ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Epilepsy

Drugs mentioned

• Xcopri (cenobamate)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Autoimmune Epilepsy | Status: ENROLLING_BY_INVITATION